|
BE794096A
(fr)
|
1972-08-07 |
1973-05-16 |
Lepetit Spa |
Oxazoles 2,4,5-trisubstitues et leur preparation
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
JPH06310767A
(ja)
|
1993-04-26 |
1994-11-04 |
Nec Corp |
寒剤容器の断熱支持構造
|
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
|
CA2744096C
(en)
|
1996-07-31 |
2013-07-30 |
Laboratory Corporation Of America Holdings |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
DE19653355A1
(de)
|
1996-12-20 |
1998-06-25 |
Dresden Arzneimittel |
Neue, antikonvulsiv wirkende Aminoimidazole und Verfahren zu ihrer Herstellung
|
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
BR0111754A
(pt)
|
2000-06-28 |
2003-04-29 |
Astrazeneca Ab |
Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
|
|
AU2479702A
(en)
|
2000-10-30 |
2002-05-15 |
Janssen Pharmaceutica Nv |
Tripeptidyl peptidase inhibitors
|
|
US7361665B2
(en)
|
2002-07-09 |
2008-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
|
AU2003902208A0
(en)
*
|
2003-05-08 |
2003-05-22 |
Fujisawa Pharmaceutical Co., Ltd. |
Inhibitor of cox
|
|
ATE465731T1
(de)
|
2003-10-23 |
2010-05-15 |
Ab Science |
2-aminoaryloxazol-verbindungen als tyrosinkinase- hemmer
|
|
KR101792651B1
(ko)
*
|
2004-05-14 |
2017-11-20 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물
|
|
GB0504753D0
(en)
|
2005-03-08 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2623327A1
(en)
|
2005-10-07 |
2007-04-19 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
|
|
DK200600313A
(da)
|
2006-03-03 |
2006-03-13 |
Novo Nordisk As |
Treating type 2 diabetes or metabolic syndrome with an interleukin 1beta inhibitor or an interleukin 1beta synthesis or release inhibitor
|
|
WO2007131953A1
(en)
|
2006-05-12 |
2007-11-22 |
Ab Science |
A new process for the synthesis of 2-aminoxazole compounds
|
|
US20090093452A1
(en)
|
2006-08-24 |
2009-04-09 |
Pfizer Inc. |
Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives
|
|
JO2701B1
(en)
*
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
|
GB0709031D0
(en)
*
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
|
EP2278969B1
(en)
|
2008-04-21 |
2013-02-13 |
Merck Sharp & Dohme Corp. |
Inhibitors of Janus kinases
|
|
GB0820819D0
(en)
|
2008-11-13 |
2008-12-24 |
Sareum Ltd |
Pharmaceutical compounds
|
|
EP2320293A1
(en)
*
|
2009-11-05 |
2011-05-11 |
Koninklijke Philips Electronics N.V. |
Sleep element for improving the sleep of a person
|
|
CN102812022B
(zh)
*
|
2010-01-12 |
2016-02-03 |
Ab科学有限公司 |
噻唑和噁唑激酶抑制剂
|
|
US9062038B2
(en)
|
2010-08-11 |
2015-06-23 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
ES2566205T3
(es)
|
2012-03-02 |
2016-04-11 |
Sareum Limited |
Inhibidores de quinasa TYK2
|